Neutrophil function and glutathione-peroxidase (GSH-px) activity in healthy individuals after treatment with N-acetyl-L-cysteine

Biomedicine and Pharmacotherapy

Volumn 51, Issue 9, 1997, Pages 388-390

  Urban, T ^a   Akerlund B ^a   Jarstrand, C ^c   Lindeke, B ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Huddinge/Swed Acad of P   (Sweden)

^c Huddinge/Swed Acad of P ^*

Author keywords

Glutathione peroxidase (GSH px); N Acetyl L cysteine; Neutrophil function; Oxidative metabolism

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; GLUTATHIONE PEROXIDASE; SUPEROXIDE;

ADULT; AEROBIC METABOLISM; ARTICLE; CELL FUNCTION; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; NEUTROPHIL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030699339     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)89431-0     Document Type: Article

References (21)

1. 1 Babior BM. Oxidants from phagocytes: agents of defence and destruction. Blood 1984;64:959-66
2. 2 Bajal MS, Kew RR, Webster RO, Hyers TM. Priming of human neutrophil functions by tumor necrosis factor alpha. Inflammation 1992;16:240-9
3. 3 Böyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968;21(Suppl 97):9-29
4. 4 Bridgeman MME, Marsden M, MacNee W, Flenley DC, Ryle AP. Cysteine and glutathione concentration in plasma and bronkoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax 1991;46:39-42
5. 5 Bringham KL. Oxidant stress and adult respiratory distress syndrome. Eur Respir J 1990;3(Suppl 11):4825-8
6. 6 Burk RF, Hill KE. Regulations of selenoproteins. Annu Rev Nutr 1993;13:65-81
7. 7 Hed J. The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested micro-organisms in phagocytosis. FEMS Microbiol Lett 1977;1:357-61
8. 8 Jarstrand C. The NBT (nitroblue tetrazolium) activity of neutrophilic granulocytes in patients with influenza A. Scand J Infect Dis 1977;9:5-7
9. 9 Klebanoff S. Clark RA. The Neutrophil. Function and Clinical Disorders. Amsterdam: North Holland Publ Co, 1978
10. 10 Lauterberg BH, Corcoran GB, Mitchell JR. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 1983;71:980-91
11. 11 Lehrer RI, Ganz T, Selsted ME, Babior ME, Carnutte JT. Neutrophils and host defence. Ann Intern Med 1988;109:127-42
12. 12 Levander OA, DeLoach DP, Morris VC, Moser PB. Platelet glutathione peroxidase activity as an index of selenium status in rats. J Nutr 1983;113:55-63
13. 13 Malek HL, Gallin JL. Neutrophils in human diseases. N Engl J Med 1987;317:687-94
14. 14 Mårtenson J, Gustavsson J, Larsson A. A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency. J Inherit Metab Dis 1989;12:120-30
15. 15 Mayer M. Noble M. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic-factor mediated cell survival in vitro. Proc Natl Acad Sci USA 1994;91:7496-500
16. 16 Nelson RD, McGormak RT, Fiegel VD. Chemotaxis of human leukocytes under agarose. In: Gallin JL, Quie PG, eds. Leukocyte Chemotaxis: Methods, Physiology & Clinical Implications. New York: Raven Press, 1977;25-9
17. 17 Öhman L, Dahlgren C, Follin P, Lew D, Stendahl O. N-acetylcysteine enhances receptor mediated phagocytosis by human neutrophils. Agents Actions 1992;36:271-7
18. 18 Paulsen O, Forsgren A. Effects of N-acetylcysteine on human polymorphonuclear leukocytes. APMIS 1989;97:115-9
19. 19 Quay de B, Malinverni R, Lautenberg BH. Glutatathione depletion in HIV infected patients; role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 1992;6:815-9
20. 20 Sjödin K, Nilsson E, Hallberg A, Tunek A. Metabolism of N-acetylcysteine. Biochem Pharmacol 1989;38:3981-5
21. 21 Sönnerborg A, Jarstrand C. Nitroblue Tetrazolium (NBT) reduction by neutrophilic granulocytes in patients with HTLV-III infection. Scand J Infect Dis 1986;18:101-5